News

An AI tool that can analyse abnormalities in the shape and form of blood cells, and with greater accuracy and reliability than human experts, could change the way conditions such as leukaemia are diagnosed, finds a study co-led by a UCL academic.

Professor Sarah Tabrizi, Director of the UCL Huntington’s Disease Centre, has been awarded the British Neuroscience Association (BNA) Outstanding Contribution to Neuroscience Award for 2025, the association’s top annual prize.

The UK Dementia Trials Network, led by a UCL professor of neurology, is establishing a dedicated nationwide network of Dementia Research Nurses.

A total of 17 academics from the UCL Faculty of Brain Sciences have been identified in Clarivate’s annual ‘Highly Cited Researchers List’ 2025.

This year’s symposium, held on 25th November 2025, focused on ‘Metabolic and Mitochondrial disorders’.

We're delighted to launch the 2024-25 Annual Review of the UCL Queen Square Institute of Neurology which provides an overview of the activity and achievements of the Institute in the past year.